< Back to companies
Aetion

Aetion

Real-world evidence platform using causal inference, epidemiologic methods, and AI to generate evidence for biopharma, medtech, payers, and regulators.

Get Involved in Aetion

Why it matters

Evidence generation is a bottleneck for drugs, devices, diagnostics, and digital health. Aetion provides infrastructure for decision-grade real-world evidence.

Products

📦

Aetion Evidence Platform

Real-world evidence platform for generating decision-grade evidence.

Learn more →

What the company reports

Claims are attributed to their source and not independently verified unless noted.

  • Datavant announced it would acquire Aetion in 2025.

    Company statessource →
  • Aetion supports real-world evidence generation for biopharma customers.

    Company statessource →

Core Technology

Real-World Data, Causal Inference, Epidemiology, AI, Evidence Platform

Company Info

Business Model
Enterprise SaaS, Life Sciences Contracting
Website
aetion.com/

MedStartr Index Score

?
7

What do you think of Aetion?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in Aetion